Communications mentioning Evusheld between Charlotte Taylor and the Chief Medical Officer
Dear Department of Health and Social Care,
For the period 1 July 2022 to 6 September please provide:
All papers, emails (whether a primary preparer, recipient or cc’d) or other electronic communications between Professor James Palmer and Charlotte Taylor of the Antivirals and Therapeutics Taskforce in which Evusheld (i.e. the combination of tixagevimab and cilgavimab, AZD7442 or any other name that is used by the DHSC for this) is mentioned.
Yours faithfully,
Louise Bicknell
Louise Bicknell left an annotation ()
In the absence of any response to this FOI I have referred this to the Information Commissioner on 5/11/22
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now
Louise Bicknell left an annotation ()
DHSC responded to one of the other email requests saying do not hold this information. Did not suggest who did. I have followed up with NHS England